BMJ  2006;332:624 (18 March), doi:10.1136/bmj.332.7542.624-b

News

FDA rejected contraception for political reasons

Janice Hopkins Tanne

News York

The first 150 words of the full text of this article appear below.

The US Food and Drug Administration "created a regulatory catch 22 to justify the predetermined political decision to block over the counter sales of [the emergency contraceptive] Plan B [levonorgestrel]," representative Henry Waxman, a California Democrat, claimed last week.

He sent a seven page letter relying on "previously undisclosed documents" to Andrew von Eschenbach, the acting commissioner of the FDA. In the letter he charges that the FDA "created the situation it now protests as too complex to solve" and "seriously mischaracterised its consideration of the regulatory questions at stake."

He wrote that the documents "further undermine the agency's contention that the Plan B decision was based on legitimate science-based factors." He asked Dr von Eschenbach to explain the FDA's action by 27 March 2005.

Plan B has been available on prescription in the United States since 1999. Barr Pharmaceuticals, the manufacturer, applied to the FDA to make it available . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Senators block Bush nominee to head FDA
Janice Tanne
BMJ 2006 332: 686. [Extract] [Full Text] [PDF]

FDA ducks decision on emergency contraceptive
Janice Hopkins Tanne
BMJ 2005 331: 596. [Extract] [Full Text] [PDF]

In brief
BMJ 2005 331: 532. [Extract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ